Michael Blom is currently the Director of Precision Oncology Portfolio Strategy & Management at Exact Sciences, where they lead the Breast Cancer Portfolio Strategy. Previously, they served as the Sr. Director of Breast Cancer Marketing at Novartis Oncology, overseeing the Kisqali indication launch. With extensive experience in the pharmaceutical industry, Michael held various positions at Pfizer, including Director of Marketing for the Oncology Business Unit and was instrumental in the launch of Inlyta. They began their career at Eli Lilly as a Hospital Sales Representative and have also contributed to companies such as Strativa Pharmaceuticals and Bayer Pharmaceuticals. Michael earned a Bachelor's degree in Communication and Media Studies from Syracuse University.
This person is not in any teams
This person is not in any offices